iPS Academia Japan, Inc.

Sharing the fruits of iPS cell research
for the good of all humanity

Japanese

What's New

News room


License-Out 2016/12/09

License Agreement Has Been Entered with Censo Biotechnologies Ltd.

We executed a non-exclusive license agreement with Censo Biotechnologies Ltd. which provides iPS cells, iPS cell derived cells and related services for research use, on the patents related to iPS cells technology which we have been granted a sublicensing right from Kyoto University.

Censo Biotechnologies Ltd.

License-Out 2016/12/05

License Agreement in Regard to a Patented Invention by the Technion-Israel Institute of Technology, exclusively held by Accellta Ltd., Has Been Entered with iPS PORTAL

We executed a non-exclusive license agreement with iPS PORTAL, Inc. on a patented invention by the Technion-Israel Institute of Technology entitled “Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same” (Our Ref. No. AJ089 / Patent No. JP4613069), which has been exclusively held by Accellta Ltd., and of which we have been granted a non-exclusive license with sublicense right in Japan.

We are sure that the patent will contribute to many company’s business since the patent is highly important for using iPS cells under xeno-free and feeder cells-free conditions. Please feel free to contact us if you are interested in the patent for your iPS cell business in Japan.

License-Out 2016/11/15

License Agreement in Regard to a Patented Invention by the Technion-Israel Institute of Technology, exclusively held by Accellta Ltd., Has Been Entered with Shionogi

We executed a non-exclusive license agreement with Shionogi & Co., Ltd. on a patented invention by the Technion-Israel Institute of Technology entitled “Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same” (Our Ref. No. AJ089 / Patent No. JP4613069), which has been exclusively held by Accellta Ltd., and of which we have been granted a non-exclusive license with sublicense right in Japan.

We are sure that the patent will contribute to many company’s business since the patent is highly important for using iPS cells under xeno-free and feeder cells-free conditions. Please feel free to contact us if you are interested in the patent for your iPS cell business in Japan.

Exhibition 2016/11/11

BIO-Europe2016 in Germany

We presented our exhibition in BIO-Europe2016 in Cologne, Germany from November 7th (Mon.) till November 9th (Fri.), 2016. We very much appreciate many meetings in Munich regarding our possible collaborations.

bio-euro-2016-03 bio-euro-2016-01

Exhibition 2016/10/17

BioJapan2016 in Yokohama

We very much appreciate your visits to our booth at “BioJapan2016” in Yokohama from October 12th (Wed) till October 14th (Fri), 2016. The exhibition was successfully finished.

biojapan2016-2  biojapan2016-1

License-Out 2016/09/07

License Agreement Has Been Entered with BrainXell, Inc.

We executed a non-exclusive license agreement with BrainXell, Inc. which provides neural cell products and services for research use, on the patents related to iPS cells technology which we have been granted a sublicensing right from Kyoto University.

BrainXell, Inc.

Other 2016/08/29

A New Basic Patent on iPS Cell Technology Has Been Issued in Japan

A new member of the basic patent family on the iPS cell technology which has been first established in the world by the research group of Prof. Shinya Yamanaka, the director of iPS Cell Research and Application (CiRA) at Kyoto University has been issued in Japan on June 3 2016. (Our Ref. No. AJ001(JP)-08 / Patent No.5943324). Accordingly, a total of eight family members of the basic patent on the Yamanaka iPS cell technology has been issued in Japan.

The 8th member of the basic patent on iPS cell technology in Japan, as well as the 7th member (Our Ref. No. AJ001(JP)-07 / Patent No.5603282), is a product patent which covers iPS cell itself. The effects of these two patents in accordance with their claims are different from those of other six members which are process patents relating to the method of generating iPS cells. As a result, Kyoto University now hold broad patent right which covers iPS cell technology from both aspects of the cell and the production method regardless of vector type used in Japan.

All of eight family members of the basic patent on the Yamanaka iPS cell technology are listed in iPS Academia Japan’s Patent Portfolio, and are licensable from us. Please feel free to contact us if you are interested in licensing such patents for your iPS cell business in Japan.

License-In 2016/08/22

Agreement Has Been Executed with Osaka University

We executed an agreement with Osaka University in order to spread the research and application of iPS cell technologies. In addition to our prior licensing activities in regards to both some patents from Osaka University and the basic patents in our patent portfolio, we will make continuous efforts with Osaka University for contributing to society through sharing the fruits of iPS cell research under the terms of the agreement.

License-Out 2016/07/19

License Agreement Has Been Entered with LAgen Laboratories

We executed a non-exclusive license agreement with LAgen Laboratories which provides iPS cell derived cells and services for such cells’ generation for research use, on the patents related to iPS cells technology which we have been granted a sublicensing right from Kyoto University.

LAgen Laboratories

Exhibition 2016/06/10

2016 BIO International Convention in San Francisco

We presented our exhibition in Japan Pavilion hosted by JETRO at “2016 BIO International Convention” in San Francisco from June 6th (Mon.) till June 9th (Thu.), 2016.

We very much appreciate many meetings in San Francisco regarding our possible collaborations.

BIO2016 entrance BIO2016 iPSAJ

1 / 712345...Last »